Recent advances in managing gastrointestinal stromal tumor

由 Duffaud, Florence, Le Cesne, Axel
發表在 F1000Res (2017)

Optimizing Tyrosine Kinase Inhibitor Therapy in Gastrointestinal Stromal Tumors: Exploring the Benefits of Continuous Kinase Suppression

由 Le Cesne, Axel, Blay, Jean-Yves, Reichardt, Peter, Joensuu, Heikki
出版 2013

Targeting the VEGF Pathway in Osteosarcoma

由 Assi, Tarek, Watson, Sarah, Samra, Bachar, Rassy, Elie, Le Cesne, Axel, Italiano, Antoine, Mir, Olivier
發表在 Cells (2021)

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study

由 Verschoor, Arie Jan, Litière, Saskia, Marréaud, Sandrine, Judson, Ian, Toulmonde, Maud, Wardelmann, Eva, LeCesne, Axel, Gelderblom, Hans
發表在 Clin Sarcoma Res (2020)

PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target

由 Bertucci, François, Finetti, Pascal, Monneur, Audrey, Perrot, Delphine, Chevreau, Christine, Le Cesne, Axel, Blay, Jean‐Yves, Mir, Olivier, Birnbaum, Daniel
發表在 Mol Oncol (2019)

Outcome of Patients with Soft‐Tissue Sarcomas: An Age‐Specific Conditional Survival Analysis

由 Bourcier, Kevin, Dinart, Derek, Le Cesne, Axel, Honoré, Charles, Meeus, Pierre, Blay, Jean‐Yves, Michot, Audrey, Le Loarer, François, Italiano, Antoine
發表在 Oncologist (2019)

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

由 Bertucci, François, Finetti, Pascal, Perrot, Delphine, Leroux, Agnès, Collin, Françoise, Le Cesne, Axel, Coindre, Jean-Michel, Blay, Jean-Yves, Birnbaum, Daniel, Mamessier, Emilie
發表在 Oncoimmunology (2017)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

由 Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
發表在 BMC Cancer (2015)

Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First‐Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials

由 Younger, Eugenie, Litière, Saskia, Le Cesne, Axel, Mir, Olivier, Gelderblom, Hans, Italiano, Antoine, Marreaud, Sandrine, Jones, Robin Lewis, Gronchi, Alessandro, van der Graaf, Winette T.A.
發表在 Oncologist (2018)

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study

由 Brodowicz, Thomas, Liegl-Atzwanger, Bernadette, Penel, Nicolas, Mir, Olivier, Blay, Jean-Yves, Kashofer, Karl, Le Cesne, Axel, Decoupigny, Emilie, Wallet, Jennifer, Hamacher, Rainer, Le Deley, Marie-Cecile
發表在 Cancers (Basel) (2020)

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

由 Cupissol Didier, Rios Maria, Adenis Antoine, Bui Binh, Ray-Coquard Isabelle, Fayette Jerome, Bertucci François, Cassier Philippe A, Blesius Aurore, Pérol David, Blay Jean-Yves, Le Cesne Axel
出版 2011-02-01

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

由 Blesius, Aurore, Cassier, Philippe A, Bertucci, François, Fayette, Jerome, Ray-Coquard, Isabelle, Bui, Binh, Adenis, Antoine, Rios, Maria, Cupissol, Didier, Pérol, David, Blay, Jean-Yves, Le Cesne, Axel
出版 2011

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

由 Duffaud, Florence, Even, Caroline, Ray-Coquard, Isabelle, Bompas, Emmanuelle, Khoa-Huynh, Thanh, Salas, Sebastien, Cassier, Philippe, Dufresne, Armelle, Bonvalot, Sylvie, Ducimetiere, Francoise, Le Cesne, Axel, Blay, Jean-Yves
出版 2012

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

由 Sanfilippo, Roberta, Dileo, Palma, Blay, Jean-Yves, Constantinidou, Anastasia, Le Cesne, Axel, Benson, Charlotte, Vizzini, Laura, Contu, Marianna, Baldi, Giacomo G., Dei Tos, Angelo P., Casali, Paolo G.
發表在 Anticancer Drugs (2015)

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy...

由 Bétrian, Sarah, Bergeron, Christophe, Blay, Jean-Yves, Bompas, Emmanuelle, Cassier, Philippe A., Chevallier, Laure, Fayette, Jérome, Girodet, Magali, Guillemet, Cécile, Le Cesne, Axel, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine
發表在 Clin Sarcoma Res (2017)

Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate

由 Pautier, Patricia, Locher, Clara, Robert, Caroline, Deroussent, Alain, Flament, Caroline, Le Cesne, Axel, Rey, Annie, Bahleda, Ratislav, Ribrag, Vincent, Soria, Jean-Charles, Vassal, Gilles, Eggermont, Alexander, Zitvogel, Laurence, Chaput, Nathalie, Paci, Angelo
出版 2013

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

由 Toulmonde, Maud, Penel, Nicolas, Adam, Julien, Chevreau, Christine, Blay, Jean-Yves, Le Cesne, Axel, Bompas, Emmanuelle, Piperno-Neumann, Sophie, Cousin, Sophie, Grellety, Thomas, Ryckewaert, Thomas, Bessede, Alban, Ghiringhelli, François, Pulido, Marina, Italiano, Antoine
發表在 JAMA Oncol (2017)

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarco...

由 Perrier, Lionel, Rascle, Pauline, Morelle, Magali, Toulmonde, Maud, Ranchere Vince, Dominique, Le Cesne, Axel, Terrier, Philippe, Neuville, Agnès, Meeus, Pierre, Farsi, Fadila, Ducimetière, Françoise, Blay, Jean-Yves, Ray Coquard, Isabelle, Coindre, Jean-Michel
發表在 PLoS One (2018)

Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group

由 Malouf, Gabriel G., Beinse, Guillaume, Adam, Julien, Mir, Olivier, Chamseddine, Ali N., Terrier, Philippe, Honore, Charles, Spano, Jean‐Philippe, Italiano, Antoine, Kurtz, Jean‐Emmanuel, Coindre, Jean‐Michel, Blay, Jean‐Yves, Le Cesne, Axel
發表在 Oncologist (2019)

Options thérapeutiques de prise en charge des sarcomes durant la pandémie COVID-19 : propositions du groupe sarcome français

由 Penel, Nicolas, Bonvalot, Sylvie, Minard, Véronique, Orbach, Daniel, Gouin, François, Corradini, Nadège, Brahmi, Mehdi, Marec-Berard, Perrine, Briand, Sylvain, Gaspar, Nathalie, Llacer, Carmen, Carrere, Sébastien, Dufresne, Armelle, Le Cesne, Axel, Blay, Jean-Yves
發表在 Bull Cancer (2020)